diabetes presentation rakesh kumar
TRANSCRIPT
Diabetes Mellitus:Diabetes Mellitus: Three situations Three situations
Love & Best Wishes to the young friendsLove & Best Wishes to the young friendsRakesh Kumar, DA, MDRakesh Kumar, DA, MD
ProfessorProfessor
Anesthesiology, Intensive Care & Perioperative MedicineAnesthesiology, Intensive Care & Perioperative MedicineMAMC & Associated Hospitals, New DelhiMAMC & Associated Hospitals, New Delhi
What are the diagnostic yardsticks What are the diagnostic yardsticks for DM?for DM?
What is impaired fasting glycemia?What is impaired fasting glycemia? A BS of 180 mg.dlA BS of 180 mg.dl-1-1=How many =How many
mmol.Lmmol.L-1-1?? If venous BS is 110 mg.dlIf venous BS is 110 mg.dl-1-1, what is , what is
capillary BS?capillary BS?
Reproducible demonstration of fasting Reproducible demonstration of fasting hyperglycemia: FBS > 110 mg% (6.1 mmol Lhyperglycemia: FBS > 110 mg% (6.1 mmol L-1-1) ) (Serum/plasma sugar > 126 mg% [7 mmol L(Serum/plasma sugar > 126 mg% [7 mmol L-1-1, , OROR
A ‘casual’ (R) BS of > 180 mg% [10 mmol LA ‘casual’ (R) BS of > 180 mg% [10 mmol L-1-1], ], OR OR
Oral GTT producing a result in the diabetic Oral GTT producing a result in the diabetic range. range.
BS concentrations between 100 – 110 mg% BS concentrations between 100 – 110 mg% (5.6-6.1 mmol L(5.6-6.1 mmol L-1-1) ) ‘impaired fasting ‘impaired fasting glycemia’. glycemia’.
What are the factors What are the factors affecting the perioperative affecting the perioperative anesthetic management of anesthetic management of
DM?DM?
Type of DMType of DM MedicationMedication End-organ changes End-organ changes Nature of surgery Nature of surgery Urgency of surgeryUrgency of surgery Level of glycemic control Level of glycemic control
Case 1Case 1
60 year old, 60 kg man, height 60 year old, 60 kg man, height 165 cm; scheduled for 165 cm; scheduled for abdominoperineal resection of abdominoperineal resection of Ca. rectumCa. rectum
Known diabeticKnown diabetic BG: (F) = 120, (PP) = 170 mg.dlBG: (F) = 120, (PP) = 170 mg.dl-1-1
What would you want to find out from history, examination and investigations?
Treatment historyTreatment history
Two main categories of drugs?Two main categories of drugs?
What are their subdivisions?What are their subdivisions?
InsulinsInsulins
Preparation Type Onset(hrs)
Peak(hrs)
Duration(hrs)
Conventional (standard)
[Contain ≥ 1% i.e. 10,000 ppm of other proteins (proinsulin, proteins, insulin derivatives etc.)]
Short actingRegular (soluble) Insulin
Prompt Insulin Zinc Suspension (amorphous) or semilente
0.5 -1
1
2-4
3-6
6-8
12-16
Intermediate actingInsulin Zinc Suspension or Lente
(Ultra: Semi=7:3)Neutral Protamine Hagedorn (NPH)
or Isophane Insulin
1-2
1-2
8-10
8-10
20-24
20-24
Long actingExtended Insulin Zinc Suspension
(Crystalline) or UltralenteProtamine Zinc Insulin (PZI)
4-6
4-6
14-18
14-20
24-36
24-36
Insulins (contd..)Insulins (contd..)More Purified (Purified pork insulin-proinsulin <20-200ppm)
Single peak insulins(Proinsulin=50-200 ppm)Actrapid, Rapidica (=Regular insulin)Lentard, Zinulin (=Lente insulin)Actraphane, Rapimix (=Regular 30% + Isophane 70%)
0.5 -11-21-2
2-48-108-10
82224
Monocomponent (MC) insulins(Proinsulin<20 ppm)Actrapid MC (=MC Regular)Monotard MC (= MC Lente)
0.5 -11-2
2-48-10
822
Human Insulins
Human Actrapid (=human Regular)Human Monotard (=human Lente)Human Actraphane (=human soluble 30% + human Isophane 70%)Lispro (human recombinant)
0.5 -11-21-2
¼ - ½
2-48-108-10
1-2
82224
4-6
Oral antihyperglycemic Oral antihyperglycemic drugsdrugs
Drug Preparations Duration Remarks
Sulfonylureas 1st generation
- Tolbutamide
- Chlorpropamide
2nd generation- Glibenclamide
- Glipizide
- Gliclazide- Glimepiride
RASTINONARTOSINDIABINESEDIABIGON
DAONILEUGLUCONBETANASEGLYNASEMINIDIABDIAMICRONAMARYLGLYMER
6-8h
36-48h
18-24h
12-18h
12-24h12-24h
1. Increase pancreatic release of endogenous insulin and insulin receptor function
2. Cause hypoglycemia3. Glimepiride has
stronger extra pancreatic action through translocation of GLUT4 to plasma membrane & thus less chance of hypoglycemia
Biguanides Metformin Phenformin
GLYCIPHAGEDBI, DBI-TD
3-4 h1.? improves insulin
receptor functions2. Lactic acidosis (very rarely with metformin
Glinides-Repaglinide -Natglinide
PRANDIN 4-6hStimulate rapid insulin secretion (early peak without inter-prandial rise) by closing the ATP dependent potassium channel.
α-glucosidase inhibitors - Acarbose GLUCOBAY
PRECOSE
1. Decrease digestion,& absorption of carbohydrates 2. May cause diarrhea, abdominal pain
Thiazolidinediones 1st generation
-Troglitazone2nd generation
-Pioglitazone-Rosiglitazone-Darglitazone
ACTOSEAVANDIA
>3-4 wks>3-4 wks
Reverse insulin resistance in liver, adipose tissue and skeletal muscle, possibly by raising the number of glucose transporters sensitization of target cells to insulin).Chance of hepato-toxicity.
Miscellaneous - Guargum DIATAID
Dietary fiber from Indian cluster bean ‘guar’. Mixed with food, it slows glucose absorption.
Oral antihyperglycemic drugs (Contd..)Oral antihyperglycemic drugs (Contd..)
Standard of BS ControlStandard of BS Control NephropathyNephropathy Ischemic heart disease, CHF and Ischemic heart disease, CHF and
CardiomyopathyCardiomyopathy Autonomic neuropathyAutonomic neuropathy RetinopathyRetinopathy Stiff joint syndromeStiff joint syndrome Electrolyte & metabolic Electrolyte & metabolic
derangementderangement
To Assess History and Examination Investigation
Standard of BS Control
- Hyper/Hypoglycemic episodes- Medication and Compliance
- BS (fasting, PP)- GTT (if required)- Glycosylated Hb (HbA1c)
Standard of BS ControlStandard of BS Control NephropathyNephropathy Ischemic heart disease, CHF and Ischemic heart disease, CHF and
CardiomyopathyCardiomyopathy Autonomic neuropathyAutonomic neuropathy RetinopathyRetinopathy Stiff joint syndromeStiff joint syndrome Electrolyte & metabolic Electrolyte & metabolic
derangementderangement
To Assess History and Examination
Investigation
Nephropathy - H/o hypertension, swelling of face and body
- Hypertension and its medication
- Urine – Proteins Sugar
- Microalbuminuria on a timed overnight collection.
- B. Urea, S. Creatinine, S. Electrolytes irrespective of age.
Standard of BS ControlStandard of BS Control NephropathyNephropathy Ischemic heart disease, CHF and Ischemic heart disease, CHF and
CardiomyopathyCardiomyopathy Autonomic neuropathyAutonomic neuropathy RetinopathyRetinopathy Stiff joint syndromeStiff joint syndrome Electrolyte & metabolic Electrolyte & metabolic
derangementderangement
To Assess History and Examination Investigation
Ischemic heart disease, CHF and Cardiomyopathy
- Angina or MI- Breathlessness,
swelling of feet- Poor exercise tolerance- Edema feet, enlarged
liver, raised JVP, basal crepts, S3/S4
- ECG- X-ray Chest
Standard of BS ControlStandard of BS Control NephropathyNephropathy Ischemic heart disease, CHF and Ischemic heart disease, CHF and
CardiomyopathyCardiomyopathy Autonomic neuropathyAutonomic neuropathy RetinopathyRetinopathy Stiff joint syndromeStiff joint syndrome Electrolyte & metabolic Electrolyte & metabolic
derangementderangement
To Assess History and Examination Investigation
Autonomic neuropathy
- Early satiety, lack of sweating- Gastroparesis in the form of
vomiting, nocturnal diarrhea, abdominal distension.
- Orthostatic hypotension- Bladder atony and urinary
retention- Impotence- Palpitation- Sensory discomfort of lower limbs- Resting tachycardia- Irregular pulse- Dense peripheral neuropathy.
- Valsava: Ratio of the Longest R-R to the shortest R-R (N > 1.21)
- Beat-to-beat variation with deep breathing obtunded: Mean of (maximum HR – minimum HR) of 3 cycles of 6bpm (< 5bpm)
(N > 15 bpm) - HR response to
standing obtunded: Ratio of Longest R-R around 30th beat after standing to the Shortest R-R around 15th beat after standing (N > 1.04)
To Assess H / E Investigation
Autonomic neuropathy (continued)
- SBP response to standing: BP(lying) - BP(Standing) (>30 mm Hg) (N<10 mmHg)
- DBP response to sustained handgrip: Handgrip sustained at 30% of maximum squeeze for upto 5 minute & BP every minute. DBP just before release – Initial DBP. (N > 16 mmHg)
Standard of BS ControlStandard of BS Control NephropathyNephropathy Ischemic heart disease, CHF and Ischemic heart disease, CHF and
CardiomyopathyCardiomyopathy Autonomic neuropathyAutonomic neuropathy RetinopathyRetinopathy Stiff joint syndromeStiff joint syndrome Electrolyte & metabolic Electrolyte & metabolic
derangementderangement
To Assess History and Examination
Investigation
Retinopathy - Vision deterioration
- Ophthalmologic examination
Standard of BS ControlStandard of BS Control NephropathyNephropathy Ischemic heart disease, CHF and Ischemic heart disease, CHF and
CardiomyopathyCardiomyopathy Autonomic neuropathyAutonomic neuropathy RetinopathyRetinopathy Stiff joint syndromeStiff joint syndrome Electrolyte & metabolic Electrolyte & metabolic
derangementderangement
To Assess History and Examination
Investigation
Stiff joint syndrome
- Stiffness in hand joints- Inability to
approximate the palmar surfaces of phalangeal joints.
- “Prayer Sign”- Non-familial short
stature- Tight-waxy skin
- X-ray cervical spine to delineate limited atlantoaxial extension.
Standard of BS ControlStandard of BS Control NephropathyNephropathy Ischemic heart disease, CHF and Ischemic heart disease, CHF and
CardiomyopathyCardiomyopathy Autonomic neuropathyAutonomic neuropathy RetinopathyRetinopathy Stiff joint syndromeStiff joint syndrome Electrolyte & metabolic Electrolyte & metabolic
derangementderangement
To Assess History and Examination
Investigation
Electrolyte & metabolic derangement
- Non-Compliance of drug
- Severe infection or starvation
- Poor control in the past few days/weeks
- S/S of hypoglycemia or ketoacidosis
- ABG and electrolytes
Case 1Case 1 60 year old, 60 kg man, height 165 60 year old, 60 kg man, height 165
cm; scheduled for cm; scheduled for abdominoperineal resection of Ca. abdominoperineal resection of Ca. rectumrectum
Known diabetic on Metformin and Known diabetic on Metformin and Glibenclimide, BD doseGlibenclimide, BD dose
Hypertension, CAD under checkHypertension, CAD under check BG: (F) = 120, (PP) = 170 mg.dlBG: (F) = 120, (PP) = 170 mg.dl-1-1
Switch over to insulin pre-op? Switch over to insulin pre-op? Pre-op orders?Pre-op orders?
Case 1Case 1 60 year old, 60 kg man, height 165 60 year old, 60 kg man, height 165
cm; scheduled for abdominoperineal cm; scheduled for abdominoperineal resection of Ca. rectumresection of Ca. rectum
Known diabetic on Metformin and Known diabetic on Metformin and Glibenclimide, BD doseGlibenclimide, BD dose
Hypertension, CAD under checkHypertension, CAD under check BG: (F) = 120, (PP) = 170 mg.dlBG: (F) = 120, (PP) = 170 mg.dl-1-1
Morning BG=90; ½ h intra-op=150Morning BG=90; ½ h intra-op=150
Intra-op fluids and insulin?Intra-op fluids and insulin?
Patient’sForearm
Insulin (1U/mL)
Infusion Pump
D-5 (500 mL) + K+ 10mmol
N-Saline / Colloid / Blood
Patient’sForearm
Insulin (1U/60mL)
N-Saline (500 mL) + 8U insulin
D-5 (500 mL) + K+ 10mmol @ G=0.1g/kg/h
N-Saline / Colloid / Blood as required
NO INFUSION PUMP AVAILABLE
INFUSION PUMP AVAILABLE
Vellore regimen?Vellore regimen?
Miriam A and Korula G.Miriam A and Korula G. A Simple Glucose Insulin A Simple Glucose Insulin Regimen for Perioperative Blood Glucose Regimen for Perioperative Blood Glucose Control: The Vellore Regimen. Anesth Analg Control: The Vellore Regimen. Anesth Analg 2004;99:598-6022004;99:598-602 Intraoperative blood glucose control with 1 U of insulin for every Intraoperative blood glucose control with 1 U of insulin for every
1–50 mg of blood glucose value more than 100 mg/dL added to 1–50 mg of blood glucose value more than 100 mg/dL added to 100 mL of 5% dextrose in a measured volume set100 mL of 5% dextrose in a measured volume set
Hourly monitoring of blood glucoseHourly monitoring of blood glucose
Blood glucose control was compared with the different existing Blood glucose control was compared with the different existing techniques followed in the hospitaltechniques followed in the hospital
The study group had a mean ± SD blood glucose value of 156 ± The study group had a mean ± SD blood glucose value of 156 ± 36 mg/dL, and the control group’s value was 189 ± 63 mg/dL (36 mg/dL, and the control group’s value was 189 ± 63 mg/dL (PP = = 0.003)0.003)
Poorly controlled patients (<100 & >200-mg/dL) decreased from Poorly controlled patients (<100 & >200-mg/dL) decreased from 51% to 28% (no patient less than 60 mg/dL) compared with the 51% to 28% (no patient less than 60 mg/dL) compared with the control group in which it increased from 49% to 72% (10 patients control group in which it increased from 49% to 72% (10 patients less than 60 mg/dL) (less than 60 mg/dL) (PP = 0.0013) = 0.0013)
It is a simple and effective method and combines the advantages It is a simple and effective method and combines the advantages of combined glucose insulin and variable rate insulin infusion of combined glucose insulin and variable rate insulin infusion
Ringer’s lactate?Ringer’s lactate? Bank blood?Bank blood?
Fluid and volume replacementFluid and volume replacement Lactate and is a gluconeogenic substrateLactate and is a gluconeogenic substrate Ringer’s lactate = 28 meq/L Ringer’s lactate = 28 meq/L Bank blood = variable amounts (anaerobic Bank blood = variable amounts (anaerobic
metabolism during storage) metabolism during storage) Hepatic conversion to glucose Hepatic conversion to glucose aggravation aggravation
of stress-induced hyperglycemiaof stress-induced hyperglycemia Ringer’s lactate/Blood are NOT Ringer’s lactate/Blood are NOT
contraindicated but contraindicated but inappropriateinappropriate as as these can confound the calculation of these can confound the calculation of glucose load and insulin requirements glucose load and insulin requirements somewhatsomewhat
Case 1Case 1 60 year old, 60 kg man, height 165 60 year old, 60 kg man, height 165
cm; scheduled for abdominoperineal cm; scheduled for abdominoperineal resection of Ca. rectumresection of Ca. rectum
Known diabetic on Metformin and Known diabetic on Metformin and Glibenclimide, BD doseGlibenclimide, BD dose
Hypertension, CAD under checkHypertension, CAD under check BG: (F) = 120, (PP) = 170 mg.dlBG: (F) = 120, (PP) = 170 mg.dl-1-1
Morning BG=90; ½ h intra-op=150Morning BG=90; ½ h intra-op=150
Epidural + GA planned; Epidural + GA planned;
Considerations during CN Blockade?Considerations during CN Blockade?
LA requirements lowerLA requirements lower
Risks of nerve injury higherRisks of nerve injury higher
Combination of LA with epinephrine may Combination of LA with epinephrine may pose greater risk of ischemic or pose greater risk of ischemic or edematous nerve injury (or both) in edematous nerve injury (or both) in diabeticdiabetic
Document peripheral neuropathy Document peripheral neuropathy keeps the patients and relatives informed keeps the patients and relatives informed avoids medico-legal hassles later on avoids medico-legal hassles later on
Insulin response to hyperglycemia Insulin response to hyperglycemia high thoracic (T1-T6) blockade high thoracic (T1-T6) blockade ? ? inhibited inhibited low blockade, (T9 - T12) low blockade, (T9 - T12) no effect no effect
Regional blocksRegional blocks
Case 2Case 2 40 year old, 45 kg lady40 year old, 45 kg lady Known diabetic on oral antihyperglycemicsKnown diabetic on oral antihyperglycemics High grade fever x 1wk, vomiting x till 2 High grade fever x 1wk, vomiting x till 2
days back, altered sensorium x 12 hdays back, altered sensorium x 12 h P=180 bpm, BP=70/40, BG=470 mg.dlP=180 bpm, BP=70/40, BG=470 mg.dl-1-1, , Blood Ketones (+++), pH=6.8, NaBlood Ketones (+++), pH=6.8, Na++-116, -116,
KK++- 3.4, HCO- 3.4, HCO33-10, P-10, PCO2CO2- 34, P- 34, PO2O2- 78 mmHg- 78 mmHg Emergency laparotomyEmergency laparotomy Yes/No? How quickly? What till then?Yes/No? How quickly? What till then?
Yes!Yes! 2-3 h may be enough 2-3 h may be enough
What are confounding factors in a What are confounding factors in a diabetic for emergency surgery?diabetic for emergency surgery?
Do we have to wait for the DKA to Do we have to wait for the DKA to settle before taking up the patient?settle before taking up the patient?
What are the indicators for going What are the indicators for going ahead with surgery?ahead with surgery?
At what pH do we need sodabicarb At what pH do we need sodabicarb correction; what before that?correction; what before that?
Role of insulin bolusRole of insulin bolus Any alteration in monitoring?Any alteration in monitoring? When to start KWhen to start K++, when glucose?, when glucose? DM with uncontrolled BS for semi-em DM with uncontrolled BS for semi-em
tomorrow; are you game? If yes, how; tomorrow; are you game? If yes, how; if no, why not?if no, why not?
Confounding factors in a Confounding factors in a diabetic for emergency diabetic for emergency
surgerysurgery Usually associated withUsually associated with
infectious processinfectious process pronounced hyperglycemia, pronounced hyperglycemia,
dehydration and hypovolemiadehydration and hypovolemia metabolic decompensationmetabolic decompensation ± DKA± DKA
Start aggressive treatment of DKAStart aggressive treatment of DKA complete resolution is usually not possible without complete resolution is usually not possible without
correction of the surgical problemcorrection of the surgical problem volume resuscitation (remember losses due to volume resuscitation (remember losses due to
precipitating cause)precipitating cause) partial correction of hyperglycemia, metabolic partial correction of hyperglycemia, metabolic
acidosis and ketosis acidosis and ketosis Consider bicarbonate if pH<6.9/7.0; bicarb conc. < Consider bicarbonate if pH<6.9/7.0; bicarb conc. <
10 mEq/L; hypotension unresponsive to IV fluids)10 mEq/L; hypotension unresponsive to IV fluids) insulin insulin bolusbolus & infusion as in the non surgical & infusion as in the non surgical
patient in DKApatient in DKA re-established urine output re-established urine output potassium supplementationpotassium supplementation phosphate supplementationphosphate supplementation start treatment of infectious process, if presentstart treatment of infectious process, if present
Aim: Aim: definite trend towards metabolic definite trend towards metabolic improvementimprovement
Monitor more oftenMonitor more often
Till thenTill then
Intra-op management?Intra-op management?
Post-op management?Post-op management?
What do persistent ketosis What do persistent ketosis with S. bicarb < 20 mEq/L & with S. bicarb < 20 mEq/L &
normal BG indicate?normal BG indicate?
Continue management of DKAContinue management of DKA
Monitor more oftenMonitor more often
There will usually be a rapid decrease There will usually be a rapid decrease in insulin requirements after surgery in insulin requirements after surgery
metabolic control regainedmetabolic control regained need for careful and frequent monitoring need for careful and frequent monitoring
of BS and metabolic parametersof BS and metabolic parameters Persistent ketosis with S. bicarb < 20 Persistent ketosis with S. bicarb < 20
mEq/L & normal BG indicate need for mEq/L & normal BG indicate need for intracellular glucose and insulin for intracellular glucose and insulin for reversal of lipolysisreversal of lipolysis
Most of the poorly controlled Most of the poorly controlled diabetics can be controlled in about diabetics can be controlled in about 12 h 12 h Start insulin infusionStart insulin infusion
Check blood gases and capillary glucose Check blood gases and capillary glucose hourlyhourly
Give sufficient glucose and potassium Give sufficient glucose and potassium
DM with uncontrolled BS DM with uncontrolled BS for semi-em tomorrowfor semi-em tomorrow
Diabetic ketoacidosis (DKA)Diabetic ketoacidosis (DKA) vs. vs. Hyperglycemic, hyperosmolar Hyperglycemic, hyperosmolar
nonketotic state (HHNS)nonketotic state (HHNS)
Diagnosis of DKA: pHa < 7.3, HCO3 < 15 mmol.l-
1, BG > 250 mg.dl-1 Moderate
ketonemia and ketonuria
HHNS: pHa > 7.3 HCO3 > 20mmol.l-1
BG > 28mmol.l-1 (500 mg.dl-1)
Absent/minimal serum ketones
Urinary ketones -/minimal
Osmolality > 330 mOsm.kg-1
Case 3Case 3
25 year, pregnant lady, diagnosed as 25 year, pregnant lady, diagnosed as diabeticdiabetic
What is Gestational DM?Time of occurrence?
Relevance?
Glucose intolerance which has its Glucose intolerance which has its onset in, or is first diagnosed during, onset in, or is first diagnosed during, pregnancy pregnancy
Typically occurs in latter halfTypically occurs in latter half
Thus AFTER organogenesis and thus Thus AFTER organogenesis and thus not a cause for congenital anomaliesnot a cause for congenital anomalies
Relevance of pre-existing diabetes in Relevance of pre-existing diabetes in pregnancy?pregnancy?
Organogenesis might get affected if not Organogenesis might get affected if not handled BEFORE conceptionhandled BEFORE conception
End-organs may be involvedEnd-organs may be involved Watch out for autonomic neuropathyWatch out for autonomic neuropathy
Incidence of acid aspiration may be moreIncidence of acid aspiration may be more
Airway management may be more Airway management may be more difficultdifficult
Glycolation of Hb decreases RBC OGlycolation of Hb decreases RBC O2 2
transport in pregnant patientstransport in pregnant patients
Important considerations if pregnant Important considerations if pregnant diabetic undergoes LSCS?diabetic undergoes LSCS?
Any special precautions in the neonate?Any special precautions in the neonate?
The mean umbilical cord venous blood The mean umbilical cord venous blood glucose and insulin levels are higher glucose and insulin levels are higher and glucagon levels lower in mothers and glucagon levels lower in mothers with poor BS controlwith poor BS control
Increased insulin levels lead to neonatal Increased insulin levels lead to neonatal hypoglycemia and delayed release of hypoglycemia and delayed release of glucagonsglucagons
Monitor BS level of neonate Monitor BS level of neonate
There is also evidence that hypotension There is also evidence that hypotension following regional anesthesia in the following regional anesthesia in the presence of hyperglycemia might presence of hyperglycemia might produce maternal lactic acidosis and produce maternal lactic acidosis and consequent fetal acidosisconsequent fetal acidosis
Insulin requirements may fall Insulin requirements may fall remarkably after delivery and thus remarkably after delivery and thus constant monitoring in HDU is vital in constant monitoring in HDU is vital in the post-operative periodthe post-operative period
Important considerations if pregnant Important considerations if pregnant diabetic undergoes some surgery other diabetic undergoes some surgery other than LSCS?than LSCS?
There is evidence that tight control of There is evidence that tight control of BG might be of benefit for the BG might be of benefit for the pregnantpregnant diabetic (and her future diabetic (and her future offspring)offspring)
Thus strive hard for tight control as Thus strive hard for tight control as the pregnancy is to continue after the pregnancy is to continue after anesthesia and surgeryanesthesia and surgery
Department of Anesthesiology, Intensive Care & Perioperative Medicine
MAMC & Associated Lok Nayak Hospital
WELCOMES YOU TO AIRWAY-2006BASIC & ADVANCED COURSES (Didactics + Hands-on Workshop*)
IN AIRWAY MANAGEMENT
I. BASIC COURSE for ALL MEDICOS (Didactics + Hands-on Workshop*)– Friday, February 17, 2006
II. ADVANCED COURSE for ANESTHESIOLOGISTS, INTENSIVISTS, PULMONOLOGISTS
Didactics – February 18th + Hands-on Workshop* - February 19th, 2006
(*Registration Limited to first 80 registrants for BASIC and first 120 registrants for ADVANCED Workshop)
Best of Luck!